Rocket


Overview
Financials
News + Filings

 
 

Vir Biotechnology, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues10.72.7
            Revenue growth293.9% 
Cost of goods sold129.484.2
Gross profit-118.7-81.5
            Gross margin-1112.6%-3009.5%
General and administrative29.121.7
EBITA-117.6-81.3
            EBITA margin-1101.9%-3003.0%
Amortization of intangibles1.10.2
EBIT-118.7-81.5
            EBIT margin-1112.6%-3009.5%
Pre-tax income-116.4-80.8
Income taxes-0.5-10.9
            Tax rate0.4%13.5%
Net income-115.9-69.9
            Net margin-1086.3%-2579.5%
 
Diluted EPS($3.36)($7.21)
Shares outstanding (diluted)34.59.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy